Cargando…
Verruca Vulgaris Eruption Arising in the Setting of a Tyrosine Kinase Inhibitor
A 71-year-old female with breast cancer presented with a generalized papular rash that began following the initiation of rebastinib. Examination revealed scattered pink to skin-colored verrucous papules on the forehead, extremities, and back. A biopsy showed hyperkeratosis, hypergranulosis, digitate...
Autores principales: | Muskat, Ahava, Nawrocki, Shiri, Kost, Yana, Mattis, Daiva, Amin, Bijal, McLellan, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286299/ https://www.ncbi.nlm.nih.gov/pubmed/35855241 http://dx.doi.org/10.7759/cureus.26006 |
Ejemplares similares
-
Immune Checkpoint Inhibitor-Induced Psoriasiform, Spongiotic, and Lichenoid Dermatitis: A Novel Clinicopathological Pattern
por: Kost, Yana, et al.
Publicado: (2022) -
Cutaneous metastasis as the first sign of small-cell cancer: An unexpected presentation in a patient with concurrent prostate cancer
por: Kost, Yana, et al.
Publicado: (2022) -
The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
por: Muskat, Ahava, et al.
Publicado: (2022) -
Cutaneous Horn Revisited: A Woman With a Verruca Vulgaris-Associated Cornu Cutaneum
por: Kheshvadjian, Alexander R, et al.
Publicado: (2021) -
Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study
por: Surani, Ashma S, et al.
Publicado: (2023)